Nuclear Medicine Imaging of Multiple Myeloma, Particularly in the Relapsed Setting

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-016-3576-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ixazomib in the Treatment of Relapsed Multiple Myeloma

Medical Council
2018English

Methodology of a Novel Risk Stratification Algorithm for Patients With Multiple Myeloma in the Relapsed Setting

Oncology and Therapy
Oncology
2019English

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology
Oncology
2018English

Prm272 - The Eunethta Transferability Tool: Application to Novel Treatments for Relapsed Refractory Multiple Myeloma in the Irish Healthcare Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Characterisation and Prognostic Impact of Immunoparesis in Relapsed Multiple Myeloma

British Journal of Haematology
Hematology
2020English

Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma

European Journal of Medical Research
Medicine
2010English

A Phase I Trial of Flavopiridol in Relapsed Multiple Myeloma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Interest of Pet Imaging in Multiple Myeloma

Frontiers in Medicine
Medicine
2019English

Optimizing the Use of Lenalidomide in Relapsed or Refractory Multiple Myeloma: Consensus Statement

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy